Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · CFR · Title 21 — Food and Drugs · Part 56 — Institutional Review Boards · § 56.111

§ 56.111. Criteria for IRB approval of research.

425 words·~2 min read·/us/cfr/t21/s§ 56.111·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)In order to approve research covered by these regulations the IRB shall determine that all of the following requirements are satisfied:
(1)Risks to subjects are minimized:
(i)By using procedures which are consistent with sound research design and which do not unnecessarily expose subjects to risk, and
(ii)whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes.
(2)Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the importance of the knowledge that may be expected to result. In evaluating risks and benefits, the IRB should consider only those risks and benefits that may result from the research (as distinguished from risks and benefits of therapies that subjects would receive even if not participating in the research). The IRB should not consider possible long-range effects of applying knowledge gained in the research (for example, the possible effects of the research on public policy) as among those research risks that fall within the purview of its responsibility.
(3)Selection of subjects is equitable. In making this assessment the IRB should take into account the purposes of the research and the setting in which the research will be conducted and should be particularly cognizant of the special problems of research involving vulnerable populations, such as children, prisoners, pregnant women, handicapped, or mentally disabled persons, or economically or educationally disadvantaged persons.
(4)Informed consent will be sought from each prospective subject or the subject's legally authorized representative, in accordance with and to the extent required by part 50.
(5)Informed consent will be appropriately documented, in accordance with and to the extent required by § 50.27.
(6)Where appropriate, the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects.
(7)Where appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data.
(b)When some or all of the subjects, such as children, prisoners, pregnant women, handicapped, or mentally disabled persons, or economically or educationally disadvantaged persons, are likely to be vulnerable to coercion or undue influence additional safeguards have been included in the study to protect the rights and welfare of these subjects.
(c)In order to approve research in which some or all of the subjects are children, an IRB must determine that all research is in compliance with part 50, subpart D of this chapter. [46 FR 8975, Jan. 27, 1981, as amended at 56 FR 28029, June 18, 1991; 66 FR 20599, Apr. 24, 2001]
Connections14 cite this
Citation graph
cites case law
§ 56.111
Criteria for IRB approval of research.
Fed. Reg.×14
Cites 0Cited by 14 across 1 source
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.